Jan. 8, 2026 — Compremium AG recently announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its novel solution designed to directly measure central ...
Venous Therapies
This channel includes news and new technology innovations of Venous Therapies including deep vein thrombosis (DVT) and vena cava filters.
-
-
Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of April. The picks are based on Google Analytics of the DAIC website's video ...
-
January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device for the removal of inferior vena cava (IVC) filters. The device is designed for ...
-
June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate (Pradaxa) anticoagulant oral pellets as the first oral anticoagulant to treat children ...
Jan. 8, 2026 — Compremium AG recently announced that the U.S. Food and Drug Administration (FDA) has granted ...
January 13, 2026
Sept. 9, 2025 — The American Venous Forum (AVF), International Society on Thrombosis and Haemostasis (ISTH), National ...
September 10, 2025
April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...
April 16, 2024
January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...
January 11, 2023
November 2, 2022 — The second round of late-breaking clinical trial results were announced at VIVA22 on Nov. 1 in Las ...
November 02, 2022
November 2, 2022 — A number of awards of distinction were presented during The VEINS (Venous Endovascular INterventional ...
November 02, 2022
October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were ...
October 31, 2022
October 14, 2022
Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of ...
May 09, 2022
January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...
January 04, 2022
November 22, 2021 — Fewer than 10 days of low-molecular-weight heparin (LMWH) after stenting for extensive iliofemoral ...
November 22, 2021
November 9 2021 — A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes ...
November 09, 2021
Vivasure Medical is Developing a Sutureless Venous Closure Device for Transcatheter Valve Procedures
July 15, 2021 — Vivasure Medical announced its development program for PerQseal Blue, a sutureless and fully ...
July 15, 2021
June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate ...
June 21, 2021
May 6, 2021 - Bluegrass Vascular Technologies announced the publication of a report documenting the clinical utility of ...
May 06, 2021